Pfizer COVID-19
-
Updated Pfizer COVID-19 booster enhances protection, company saysAbout 26.3 million Americans have gotten an updated booster since they rolled out in early September, according to the Centers for Disease Control and Prevention.WorldNov 4, 2022
-
Updated Pfizer Omicron booster protects against subvariants, company saysThe companies said data from a trial in adult patients showed that the booster dose led to a substantial increase in neutralizing antibody levels against the BA.4/BA.5 variants.WorldOct 13, 2022
-
Canada OKs Pfizer’s bivalent booster targeting Omicron subvariantsHealth Canada announced Friday it has approved the updated shot, which has been designed to target Omicron’s BA.4 and BA.5 subvariants.HealthOct 7, 2022
![]()
-
Health Canada OKs Pfizer COVID-19 booster shot for teens ages 16 and 17Health Canada cleared an extra dose of the vaccine for people 18 and older in November. The booster is meant to be administered six months after the primary two-dose series.HealthJun 1, 2022
![]()
-
Pfizer’s antiviral COVID-19 pill approved by U.K. regulatorsPfizer this month said Paxlovid showed near 90 per cent efficacy in preventing hospitalizations and deaths in high-risk COVID-19 patients.WorldDec 31, 2021
![]()
-
Pfizer’s oral COVID-19 pill approved by U.S. FDA for at-home useThe U.S. Food and Drug Administration authorizing Pfizer's antiviral COVID-19 pill makes it the first at-home treatment for the coronavirus.HealthDec 22, 2021
![]()
-
Pfizer’s COVID-19 pill appears effective against Omicron variant, company saysThe Canadian government announced earlier this month it has reached an agreement with Pfizer for one million courses of its treatment, pending Health Canada approval.HealthDec 14, 2021
![]()
-
Pfizer to allow other companies to make its COVID-19 pillCOVID-19 vaccine maker Pfizer has agreed to grant a license for its antiviral pill to the Medicines Patent Pool, which would allow other companies to make the treatment.HealthNov 16, 2021
![]()
